|
|
|
|
The results of this study indicate that IV IgG is unlikely to be of clinical benefit in CFS.In addition to the ongoing need for placebo- controlled trials of candidate therapies for CFS,an expanded research effort is needed to define the etiology and pathogenesis of this disorder. |
|